Company Filing History:
3 out of 41 
2 out of 62 
Years Active: 2004-2009
Title: Kazuo Dairiki: Innovator in Allergy Immunotherapy
Introduction
Kazuo Dairiki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of immunotherapy, particularly in the area of allergy treatment. With a total of 5 patents, Dairiki's work focuses on developing innovative solutions for patients suffering from pollen allergies.
Latest Patents
Dairiki's latest patents include the identification of T-cell epitope peptides from Japanese cypress (hinoki) pollen allergen molecules. By stimulating a T-cell line established from a patient with Japanese cypress pollen allergy, he has identified the T-cell epitope site. This peptide is beneficial for peptide-based immunotherapy for patients with spring tree pollinosis, including those with cross-reactivity to Japanese cypress pollen. Additionally, the peptide serves as a useful diagnostic tool for spring tree pollinosis.
Career Highlights
Throughout his career, Kazuo Dairiki has worked with prominent companies such as Meiji Dairies Corporation and Meiji Milk Products Company, Limited. His experience in these organizations has contributed to his expertise in allergy research and immunotherapy.
Collaborations
Dairiki has collaborated with notable coworkers, including Kohsuke Kino and Toshio Sone. Their joint efforts have further advanced the research and development of allergy treatments.
Conclusion
Kazuo Dairiki's innovative work in allergy immunotherapy has made a significant impact on the field. His contributions through patents and collaborations highlight his dedication to improving the lives of those affected by pollen allergies.